Report Overview
Nucleic acid vaccines represent an innovative class of immunotherapeutics that utilize genetic material—either DNA or RNA—to instruct host cells to produce specific antigens, triggering an immune response. Unlike traditional vaccines that rely on weakened pathogens or protein subunits, nucleic acid vaccines deliver synthetic genetic sequences encoding target antigens, offering advantages such as rapid development, scalability, and the potential for broader immune activation, including robust T-cell responses. DNA vaccines typically employ plasmid vectors, while mRNA vaccines leverage lipid nanoparticles for intracellular delivery, with the latter gaining prominence due to their successful deployment in COVID-19 vaccines. These vaccines are particularly promising for addressing emerging infectious diseases, cancers, and other complex conditions due to their adaptability in antigen design and manufacturing efficiency. However, challenges such as stability (especially for mRNA), delivery optimization, and long-term immunogenicity data remain areas of ongoing research and refinement.
The global Nucleic Vaccine market size was estimated at USD 4504.95 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 15.25% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nucleic Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nucleic Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nucleic Vaccine market.
Global Nucleic Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Moderna
CureVac
Inovio
Sanofi
GSK
CNBG
Hualan Bio
Zhifei Shengwu
Liaoning Chengda
BioKangtai
CanSinoBIO
Walvax Biotechnology
Fosun Pharma
Market Segmentation (by Type)
Preventive Nucleic Vaccine
Therapeutic Nucleic Vaccine
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nucleic Vaccine Market
Overview of the regional outlook of the Nucleic Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nucleic Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nucleic Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Nucleic Vaccine
1.2 Key Market Segments
1.2.1 Nucleic Vaccine Segment by Type
1.2.2 Nucleic Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Nucleic Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Nucleic Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Nucleic Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Nucleic Vaccine Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Nucleic Vaccine Product Life Cycle
3.3 Global Nucleic Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Nucleic Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Nucleic Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nucleic Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Nucleic Vaccine Market Competitive Situation and Trends
3.8.1 Nucleic Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nucleic Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Nucleic Vaccine Industry Chain Analysis
4.1 Nucleic Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Nucleic Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nucleic Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nucleic Vaccine Market
5.7 ESG Ratings of Leading Companies
6 Nucleic Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nucleic Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Nucleic Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global Nucleic Vaccine Price by Type (2020-2025)
7 Nucleic Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nucleic Vaccine Market Sales by Application (2020-2025)
7.3 Global Nucleic Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Nucleic Vaccine Sales Growth Rate by Application (2020-2025)
8 Nucleic Vaccine Market Sales by Region
8.1 Global Nucleic Vaccine Sales by Region
8.1.1 Global Nucleic Vaccine Sales by Region
8.1.2 Global Nucleic Vaccine Sales Market Share by Region
8.2 Global Nucleic Vaccine Market Size by Region
8.2.1 Global Nucleic Vaccine Market Size by Region
8.2.2 Global Nucleic Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America Nucleic Vaccine Sales by Country
8.3.2 North America Nucleic Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nucleic Vaccine Sales by Country
8.4.2 Europe Nucleic Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nucleic Vaccine Sales by Region
8.5.2 Asia Pacific Nucleic Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nucleic Vaccine Sales by Country
8.6.2 South America Nucleic Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nucleic Vaccine Sales by Region
8.7.2 Middle East and Africa Nucleic Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Nucleic Vaccine Market Production by Region
9.1 Global Production of Nucleic Vaccine by Region(2020-2025)
9.2 Global Nucleic Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Nucleic Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nucleic Vaccine Production
9.4.1 North America Nucleic Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Nucleic Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nucleic Vaccine Production
9.5.1 Europe Nucleic Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Nucleic Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nucleic Vaccine Production (2020-2025)
9.6.1 Japan Nucleic Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Nucleic Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nucleic Vaccine Production (2020-2025)
9.7.1 China Nucleic Vaccine Production Growth Rate (2020-2025)
9.7.2 China Nucleic Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Moderna
10.1.1 Moderna Basic Information
10.1.2 Moderna Nucleic Vaccine Product Overview
10.1.3 Moderna Nucleic Vaccine Product Market Performance
10.1.4 Moderna Business Overview
10.1.5 Moderna SWOT Analysis
10.1.6 Moderna Recent Developments
10.2 CureVac
10.2.1 CureVac Basic Information
10.2.2 CureVac Nucleic Vaccine Product Overview
10.2.3 CureVac Nucleic Vaccine Product Market Performance
10.2.4 CureVac Business Overview
10.2.5 CureVac SWOT Analysis
10.2.6 CureVac Recent Developments
10.3 Inovio
10.3.1 Inovio Basic Information
10.3.2 Inovio Nucleic Vaccine Product Overview
10.3.3 Inovio Nucleic Vaccine Product Market Performance
10.3.4 Inovio Business Overview
10.3.5 Inovio SWOT Analysis
10.3.6 Inovio Recent Developments
10.4 Sanofi
10.4.1 Sanofi Basic Information
10.4.2 Sanofi Nucleic Vaccine Product Overview
10.4.3 Sanofi Nucleic Vaccine Product Market Performance
10.4.4 Sanofi Business Overview
10.4.5 Sanofi Recent Developments
10.5 GSK
10.5.1 GSK Basic Information
10.5.2 GSK Nucleic Vaccine Product Overview
10.5.3 GSK Nucleic Vaccine Product Market Performance
10.5.4 GSK Business Overview
10.5.5 GSK Recent Developments
10.6 CNBG
10.6.1 CNBG Basic Information
10.6.2 CNBG Nucleic Vaccine Product Overview
10.6.3 CNBG Nucleic Vaccine Product Market Performance
10.6.4 CNBG Business Overview
10.6.5 CNBG Recent Developments
10.7 Hualan Bio
10.7.1 Hualan Bio Basic Information
10.7.2 Hualan Bio Nucleic Vaccine Product Overview
10.7.3 Hualan Bio Nucleic Vaccine Product Market Performance
10.7.4 Hualan Bio Business Overview
10.7.5 Hualan Bio Recent Developments
10.8 Zhifei Shengwu
10.8.1 Zhifei Shengwu Basic Information
10.8.2 Zhifei Shengwu Nucleic Vaccine Product Overview
10.8.3 Zhifei Shengwu Nucleic Vaccine Product Market Performance
10.8.4 Zhifei Shengwu Business Overview
10.8.5 Zhifei Shengwu Recent Developments
10.9 Liaoning Chengda
10.9.1 Liaoning Chengda Basic Information
10.9.2 Liaoning Chengda Nucleic Vaccine Product Overview
10.9.3 Liaoning Chengda Nucleic Vaccine Product Market Performance
10.9.4 Liaoning Chengda Business Overview
10.9.5 Liaoning Chengda Recent Developments
10.10 BioKangtai
10.10.1 BioKangtai Basic Information
10.10.2 BioKangtai Nucleic Vaccine Product Overview
10.10.3 BioKangtai Nucleic Vaccine Product Market Performance
10.10.4 BioKangtai Business Overview
10.10.5 BioKangtai Recent Developments
10.11 CanSinoBIO
10.11.1 CanSinoBIO Basic Information
10.11.2 CanSinoBIO Nucleic Vaccine Product Overview
10.11.3 CanSinoBIO Nucleic Vaccine Product Market Performance
10.11.4 CanSinoBIO Business Overview
10.11.5 CanSinoBIO Recent Developments
10.12 Walvax Biotechnology
10.12.1 Walvax Biotechnology Basic Information
10.12.2 Walvax Biotechnology Nucleic Vaccine Product Overview
10.12.3 Walvax Biotechnology Nucleic Vaccine Product Market Performance
10.12.4 Walvax Biotechnology Business Overview
10.12.5 Walvax Biotechnology Recent Developments
10.13 Fosun Pharma
10.13.1 Fosun Pharma Basic Information
10.13.2 Fosun Pharma Nucleic Vaccine Product Overview
10.13.3 Fosun Pharma Nucleic Vaccine Product Market Performance
10.13.4 Fosun Pharma Business Overview
10.13.5 Fosun Pharma Recent Developments
11 Nucleic Vaccine Market Forecast by Region
11.1 Global Nucleic Vaccine Market Size Forecast
11.2 Global Nucleic Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nucleic Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Nucleic Vaccine Market Size Forecast by Region
11.2.4 South America Nucleic Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nucleic Vaccine by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Nucleic Vaccine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Nucleic Vaccine by Type (2026-2033)
12.1.2 Global Nucleic Vaccine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Nucleic Vaccine by Type (2026-2033)
12.2 Global Nucleic Vaccine Market Forecast by Application (2026-2033)
12.2.1 Global Nucleic Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Nucleic Vaccine Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings
